ClinicalTrials.Veeva

Menu

The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions

A

Assiut University

Status

Not yet enrolling

Conditions

Digital Breast Tomosynthesis

Treatments

Device: digital breast tomosynthesis and mammography

Study type

Observational

Funder types

Other

Identifiers

NCT06854887
DBT &Mammography in BIRADS 4-5

Details and patient eligibility

About

Compare the diagnostic accuracy of tomosynthesis with 2D mammography in cases with suspected BI-RADS 4 or 5 to determine its potential benefit for staging

Full description

Digital breast tomosynthesis (DBT) is a promising 3D imaging technique for breast imaging that use in breast cancer detection. it acquires reconstructed volume data , the data is reconstructed secondarily in mammary slices from several radiographs acquired from different angles of view (-15◦ to +15◦ for Fuji). It theoretically improves the sensitivity of detection by enabling enhanced delimitation of the lesion margins, and the specificity by avoiding the problem of glandular superimposition, By separating overlapping breast tissues & it enhances detection of abnormalities located in different planes. DBT has higher breast cancer detection rates and lower recall rates compared with digital mammography (DM). There is also evidence of the diagnostic efficacy of DBT in women with clinical symptoms and women with screen-detected findings who have been recalled for work-up. Consequently, recommendations have been made about the role of DBT in screening asymptomatic women according to their risk levels, in evaluation of symptomatic women, and in work-up of suspicious DM findings. The main objective of this study was to compare tomosynthesis with 2D mammography in cases with suspected BI-RADS 4 or 5 anomalies, to determine its potential benefit for staging.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. BI-RADS 4 OR 5 LESION that pathologically proved to be breast cancer.
  2. No history of previous operations
  3. No history of chemotherapy or radiotherapy

Exclusion criteria

  1. BI-RADS 1 ,2,3 lesions
  2. History of previous operation

Trial contacts and locations

0

Loading...

Central trial contact

Eman Abo Elhamd; Silvia Gamal Rasmy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems